痰液宏基因组揭示亚洲人群多重耐药铜绿假单胞菌主导的重症哮喘表型
该研究在新加坡两个中心前瞻性纳入70例多族裔亚洲重症哮喘患者,对痰液行鸟枪法宏基因组测序并随访2年,发现痰宏基因组无监督聚类可分为两个簇,其中C2簇以铜绿假单胞菌等呼吸道病原体为主,与2年随访期间急性加重频率显著增加及多重耐药耐药组相关。
要点
- 重症哮喘患者痰宏基因组聚类可识别以铜绿假单胞菌为主导的C2簇。
- C2簇患者2年随访急性加重频率显著增加且耐药组呈多重耐药特征。
- C2簇的毒力组特征与支气管扩张无关,且与非哮喘支气管扩张队列相似。
核心结论
- 痰液宏基因组显示亚洲人群存在多重耐药铜绿假单胞菌主导的重症哮喘表型,其特征为临床结局较差包括急性加重增加,且独立于合并支气管扩张。
研究设计与样本
- 前瞻性评估多族裔亚洲重症哮喘队列(N=70),患者来自新加坡两个中心。
- 对痰液行鸟枪法宏基因组测序,并将宏基因组、耐药组和毒力组评估与临床结局关联。
- 患者随访2年。
主要发现
- 多族裔亚洲重症哮喘队列肺部微生物组显示假单胞菌属丰度增加。
- 痰宏基因组无监督聚类识别两个患者簇:C1(n=52)以上气道共生菌为特征,C2(n=18)以包括卡他莫拉菌、金黄色葡萄球菌及最显著的铜绿假单胞菌等已知呼吸道病原体为主。
- C2患者在2年随访中急性加重频率显著增加,且耐药组呈多重耐药特征。
- 合并或不合并支气管扩张的重症哮喘患者之间毒力组似乎无法区分;C2患者生物膜形成、效应器递送系统和微生物运动相关基因表达增加。
- C2簇与非哮喘支气管扩张队列的独立比较显示类似的气道微生物毒力模式。
临床怎么用
- 对重症哮喘患者可考虑痰液宏基因组测序识别铜绿假单胞菌主导表型。
- 识别C2表型有助于识别急性加重风险较高的患者。
- C2表型多重耐药特征提示需关注抗菌药物耐药管理。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: While the lung microbiome in severe asthma has been studied, work has employed targeted amplicon-based sequencing approaches without functional assessment with none focused on multi-ethnic Asian populations. Here we investigate the clinical relevance of microbial phenotypes of severe asthma in Asians using metagenomics. METHODS: Prospective assessment of clinical, radiological, and immunological measures were performed in a multi-ethnic Asian severe asthma cohort (N = 70) recruited across two centres in Singapore. Sputum was subjected to shotgun metagenomic sequencing and patients followed up for a 2-year period. Metagenomic assessment of sputum microbiomes, resistomes and virulomes were related to clinical outcomes. RESULTS: The lung microbiome in a multi-ethnic Asian cohort with severe asthma demonstrates an increased abundance of Pseudomonas species. Unsupervised clustering of sputum metagenomes identified two patient clusters: C1 (n = 52) characterized by upper airway commensals and C2 (n = 18) dominated by established respiratory pathogens including M. catarrhalis, S. aureus and most significantly P. aeruginosa. C2 patients demonstrated a significantly increased exacerbation frequency on 2-year follow up and an antimicrobial resistome characterized by multidrug resistance. Virulomes appear indistinguishable between severe asthmatics with or without co-existing bronchiectasis, and C2 patients exhibit increased gene expression related to biofilm formation, effector delivery systems and microbial motility. Independent comparison of the C2 cluster to a non-asthmatic bronchiectasis cohort demonstrates analogous airway microbial virulence patterns. CONCLUSION: Sputum metagenomics demonstrates a multidrug-resistant Pseudomonas-dominant severe asthma phenotype in Asians, characterized by poor clinical outcome including increased exacerbations which is independent of co-existing bronchiectasis.
引用
- Ivan, Tiew, Jaggi, et al. Sputum metagenomics reveals a multidrug resistant Pseudomonas-dominant severe asthma phenotype in an Asian population. Respirology. 2024. PMID: 39622769. doi:10.1111/resp.14863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。